Skip to main content
Contact Us
Subscribe
E-Edition
40°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Eli Lilly and Co
Recent news which mentions Eli Lilly and Co
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
December 20, 2023
Tags
Pharmaceuticals
Biotechnology
US: News
From
CNBC.com News
Treasury yields dip slightly as Fed trajectory remains in focus
December 20, 2023
Tags
Government debt
JPMORGAN DRN
Economic events
From
CNBC.com News
Treasury yields down slightly as recent trend continues
December 19, 2023
Tags
Citigroup Inc
US: News
Morgan Stanley
From
CNBC.com News
5 things to know before the stock market opens Monday
December 18, 2023
Tags
Business
Investing
Economy
From
CNBC.com News
The weight loss drug boom isn't over yet — here's what to expect in the year ahead
December 17, 2023
Tags
Weight management
Eli Lilly and Co
Health & Science
From
CNBC.com News
Patients regain weight after stopping Eli Lilly's Zepbound, study says
December 11, 2023
Tags
Pharmaceuticals
Breaking news
Biotechnology
From
CNBC.com News
Treasury yields inch higher ahead of Fed meeting
December 11, 2023
Tags
Bank of America Corp
Bonds
Central Banks
From
CNBC.com News
Biden administration asserts power to seize drug patents in move to slash high prices
December 07, 2023
Tags
Eli Lilly and Co
Politics
Breaking News: Politics
From
CNBC.com News
Cramer examines Tuesday's market 'mistakes,' points out underappreciated stocks
December 05, 2023
Tags
Foxconn Technology Co Ltd
Investing
Business
From
CNBC.com News
Eli Lilly weight loss drug Zepbound now available at pharmacies as rival Wegovy faces shortages
December 05, 2023
Tags
Biotechnology
US: News
Business
From
CNBC.com News
Cramer says the growing popularity of weight loss drugs brings new investing opportunities
December 04, 2023
Tags
Stock markets
Markets
Investment Strategy
From
CNBC.com News
Pfizer's twice-daily weight loss pill joins a long list of obesity drug flops
December 02, 2023
Tags
Novo Nordisk A/S
Business
US: News
From
CNBC.com News
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
December 01, 2023
Tags
Pharmaceuticals
Novo Nordisk A/S
Biotechnology
From
CNBC.com News
Novo Nordisk sues two pharmacies for allegedly selling tainted Wegovy, Ozempic knockoffs
November 30, 2023
Tags
Novo Nordisk A/S
Biotechnology
Business
From
CNBC.com News
Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real world study says
November 27, 2023
Tags
Pharmaceuticals
Breaking news
Biotechnology
From
CNBC.com News
This key element of ESG investing could drive real change at companies and boost returns
November 18, 2023
Tags
H/B/ Fuller Company
Breaking News: Markets
Eli Lilly and Co
From
CNBC.com News
Jim Cramer says insurance companies will pay for 'revolutionary' weight-loss drugs for their members
November 13, 2023
Tags
Eli Lilly and Co
Business News
Stock Picks
From
CNBC.com News
Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success
November 13, 2023
Tags
Business News
Biotech and Pharmaceuticals
Health care industry
From
CNBC.com News
Cramer's week ahead: Consumer spending in the spotlight with retail earnings and a new price index
November 10, 2023
Tags
Investment Strategy
Investment strategy
Mad Money
From
CNBC.com News
FDA approves Eli Lilly's tirzepatide for obesity, paving way for even wider use of blockbuster drug
November 08, 2023
Tags
Biotech and Pharmaceuticals
Business News
Health care industry
From
CNBC.com News
Eli Lilly says supply of blockbuster diabetes drug Mounjaro has improved in U.S.
November 02, 2023
Tags
Novo Nordisk A/S
Biotechnology
US: News
From
CNBC.com News
Eli Lilly results top estimates on Mounjaro strength but slashes full-year profit outlook
November 02, 2023
Tags
Novo Nordisk A/S
US: News
Business
From
CNBC.com News
Pfizer swings to quarterly loss due to Paxlovid, Covid vaccine write-offs
October 31, 2023
Tags
Pfizer Inc
Health care industry
Biotech and Pharmaceuticals
From
CNBC.com News
5 things to know before the stock market opens Monday
October 30, 2023
Tags
General Motors Co
Markets
JetBlue Airways Corp
From
CNBC.com News
Cramer's week ahead: Federal Reserve meeting, Apple and Eli Lilly earnings
October 27, 2023
Tags
Business News
McDonald's Corp
Amgen Inc
From
CNBC.com News
Treasury yields continue retreat after 10-year slips back below 5%
October 24, 2023
Tags
Delta Air Lines Inc
Wells Fargo & Co
Johnson & Johnson
From
CNBC.com News
Wall Street hikes forecasts for anti-obesity drug sales to $100 billion and beyond — A look at the numbers
October 23, 2023
Tags
Health & Science
Breaking News: Investing
Eli Lilly and Co
From
CNBC.com News
Treasury yields rise again as 10-year hovers near 5%
October 23, 2023
Tags
Eli Lilly and Co
US Economy
Prices
From
CNBC.com News
Sanofi to offer insulin product for $35 to all Americans through GoodRx
October 19, 2023
Tags
Goodrx Holdings Inc
Breaking news
Pharmaceuticals
From
CNBC.com News
'Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdles
October 14, 2023
Tags
Diabetes
Breaking News: Markets
Exercise
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.